| CEC Infection Prevention and Control Practice Handbook
|
|
|
| Framework for Managing Allied Health Staff with Identified Clinical Practice Issues
|
SESLHDPD/328 |
|
| Glargine - Safe Use of High Concentration Insulin Glargine 300 units/mL (Toujeo®)
|
SESLHDPR/638 |
|
| Ice for Human Consumption
|
SESLHDPR/362 |
|
| Idarucizumab in Urgent Dabigatran Reversal
|
SESLHDPR/571 |
|
| Industrial relations
|
SESLHDPD/248 |
|
| Infection Control: Cleaning (Shared) Patient Care Equipment Guideline
|
SESLHDGL/029 |
|
| Infection Prevention and Control CNC - Out of hours on-call role
|
SESLHDBR/093 |
|
| Infection Prevention and Control during construction, renovation or maintenance
|
SESLHDPR/374 |
Under Review |
| Influenza Clinics for Seasonal Influenza
|
SESLHDPR/277 |
|
| Influenza – Critical care escalation and management
|
SESLHDPR/270 |
|
| Information Security Incident Management Policy
|
SESLHDPD/317 |
|
| Information Security Policy
|
SESLHDPD/310 |
|
| Injury Management - Non-Work Related Injury or Illness Management
|
SESLHDPR/564 |
|
Injury Management - Recovery at Work Procedure
|
SESLHDPR/276 |
|
| Injury Management – Redeployment of Injured Employees under Workers Compensation Procedure
|
SESLHDPR/279 |
|
| Internet of Things (IoT) Policy
|
SESLHDPD/312 |
|
| Intra-Pleural Fibrinolysis - Medical Management of Empyema
|
SESLHDPR/631 |
|
| Managing Intellectual Property arising from Health Research
|
SESLHDPD/319 |
|
| Medicare Ineligible Patients – General Fees
|
SESLHDPR/425 |
|
| Medicine: Managing Intraoperative Medications
|
SESLHDPR/209 |
|
| New or altered interventional procedures, technologies or treatments – safe introduction into clinical practice
|
SESLHDPD/286 |
|
| Nursing and Midwifery Delegation: Ordering of Pathology and Imaging in eMR
|
SESLHDPD/303 |
|
| Pain Management - Intrathecal Implantable drug Delivery for Pain Management
|
SESLHDPR/294 |
|
| Radiation safety - Ionising Radiation Procedure
|
SESLHDPD/296 |
|
| Release of Patient Health Information Related to an Insurance / Compensation Claim
|
SESLHDPR/675 |
|
| Ryzodeg® - Insulin degludec/insulin aspart (Ryzodeg® 70/30) Prescribing Protocol
|
SESLHDPR/650 |
|
| SESLHD Web Content Management System (CMS) Framework
|
SESLHDHB/024 |
|
| SESLHD workers and students unvaccinated for influenza must wear a mask while providing patient care in a high risk clinical area
|
SESLHDPD/307 |
Under Review |
| Work Health and Safety - Incident Management, Investigation and Reporting Procedure
|
SESLHDPR/322 |
|
| Work Health Safety - Working Onsite Alone in Isolation
|
SESLHDPR/323 |
|
| Wound - Incontinence Associated Dermatitis (IAD)
|
SESLHDPR/205 |
|
